Clinical trial
Measurement of Neutrophil Membrane CD64 as an Early Indication of Neonatal Infection and Necrotising Enterocolitis (NEC).
NCT01005589 is registered in ClinicalTrials.gov with Newcastle-upon-Tyne Hospitals NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Measurement of Neutrophil Membrane CD64 as an Early Indication of Neonatal Infection and Necrotising Enterocolitis (NEC).
- Lead sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- June 2, 2010
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.